Data as of Aug 26
| +0.47 / +0.79%|
The 16 analysts offering 12-month price forecasts for Merck & Co Inc have a median target of 61.50, with a high estimate of 70.00 and a low estimate of 57.00. The median estimate represents a +2.16% increase from the last price of 60.20.
The current consensus among 19 polled investment analysts is to Hold stock in Merck & Co Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.